Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273-case report

CEN Case Rep. 2022 Nov;11(4):511-512. doi: 10.1007/s13730-022-00735-w. Epub 2022 Sep 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • IgA Vasculitis*
  • RNA, Messenger
  • Vaccination

Substances

  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • RNA, Messenger